Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: A retrospective analysis

Critical Care

Volumn 18, Issue 4, 2014, Pages

  De Bus, Liesbet ^a   Saerens, Lies ^a   Gadeyne, Bram ^b   Boelens, Jerina ^a   Claeys, Geert ^a   De Waele, Jan J ^a   Benoit, Dominique D ^a   Decruyenaere, Johan ^a   Depuydt, Pieter O ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; ECOLOGY; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; LOCAL ECOLOGY BASED ALGORITHM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCRIPTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVEILLANCE CULTURE BASED ALGORITHM; TERTIARY CARE CENTER; ADVERSE EFFECTS; ARTIFICIAL VENTILATION; CROSS INFECTION; DRUG EFFECTS; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; EPIDEMIOLOGICAL MONITORING; MIDDLE AGED; MULTIDRUG RESISTANCE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; STANDARDS; TREATMENT OUTCOME;

AGED; ALGORITHMS; ANTI-INFECTIVE AGENTS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ECOLOGICAL AND ENVIRONMENTAL PHENOMENA; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84904087176     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13990     Document Type: Article

References (29)

1. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012, 33:322-327.
2. Charani E, Holmes AH. Antimicrobial stewardship programmes: the need for wider engagement. BMJ Qual Saf 2013, 22:885-887. 10.1136/bmjqs-2013-002444, 24046440.
3. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268. 10.1378/chest.122.1.262, 12114368.
4. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
5. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.
6. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001, 29:1109-1115. 10.1097/00003246-200106000-00003, 11395584.
7. Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006, 130:787-793. 10.1378/chest.130.3.787, 16963676.
8. Michel F, Franceschini B, Berger P, Arnal JM, Gainnier M, Sainty JM, Papazian L. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005, 127:589-597. 10.1378/chest.127.2.589, 15706001.
9. Depuydt P, Benoit D, Vogelaers D, Decruyenaere J, Vandijck D, Claeys G, Verschraegen G, Blot S. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008, 34:675-682. 10.1007/s00134-007-0953-z, 18066522.
10. Jung B, Sebbane M, Chanques G, Courouble P, Verzilli D, Perrigault PF, Jean-Pierre H, Eledjam JJ, Jaber S. Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 2009, 35:101-107. 10.1007/s00134-008-1248-8, 18712348.
11. Kollef MH. Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Crit Care Med 2006, 34:903-905. 10.1097/01.CCM.0000202128.30405.60, 16505677.
12. Steurbaut K, Colpaert K, Gadeyne B, Depuydt P, Vosters P, Danneels C, Benoit D, Decruyenaere J, De Turck F. COSARA: integrated service platform for infection surveillance and antibiotic management in the ICU. J Med Syst 2012, 36:3765-3775. 10.1007/s10916-012-9849-8, 22527780.
13. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, Dewaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009, 37:2360-2368. 10.1097/CCM.0b013e3181a037ac, 19531951.
14. Simpelaere A, De Bus L, Claeys G, Boelens J, Seghers H, Decruyenaere J, Depuydt P. Good agreement of semiquantitative culture of blind endotracheal aspirate with quantitative culture of broncho-alveolar lavage fluid in patients with suspected ventilator-associated pneumonia. Annual congress European Society of Intensive Care Medicine (ESICM) October 1-5 2011, Berlin, Germany: E-poster 1084.
15. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003, 9:1415-1422. 10.3201/eid0911.030284, 3035560, 14718085.
16. Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254-1260. 10.1086/496986, 16206099.
17. Becher RD, Hoth JJ, Rebo JJ, Kendall JL, Miller PR. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit. Surg Infect (Larchmt) 2012, 13:352-359. 10.1089/sur.2011.056, 23268613.
18. Luna CM, Sarquis S, Niederman MS, Sosa FA, Otaola M, Bailleau N, Vay CA, Famiglietti A, Irrazabal C, Capdevila AA. Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?. Chest 2013, 144:63-71. 10.1378/chest.12-1477, 23348886.
19. Brusselaers N, Labeau S, Vogelaers D, Blot S. Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 2013, 39:365-375. 10.1007/s00134-012-2759-x, 23188467.
20. Craven DE, Chroneou A, Zias N, Hjalmarson KI. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest 2009, 135:521-528. 10.1378/chest.08-1617, 18812452.
21. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 1984, 13:9-22.
22. Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 2012, 68:1243-1255. 10.1007/s00228-012-1259-9, 22411630.
23. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011, 11:181-189. 10.1016/S1473-3099(10)70314-5, 21256086.
24. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096. 10.1136/bmj.c2096, 20483949.
25. Heenen S, Jacobs F, Vincent JL. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?. Crit Care Med 2012, 40:1404-1409. 10.1097/CCM.0b013e3182416ecf, 22430235.
26. Alvarez-Lerma F, Alvarez B, Luque P, Ruiz F, Dominguez-Roldan JM, Quintana E, Sanz-Rodriguez C. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care 2006, 10:R78. 10.1186/cc4919, 1550932, 16704742.
27. De Waele JJ, Ravyts M, Depuydt P, Blot SI, Decruyenaere J, Vogelaers D. De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?. J Crit Care 2010, 25:641-646. 10.1016/j.jcrc.2009.11.007, 20074905.
28. Cookson B, Bonten MJ, Mackenzie FM, Skov RL, Verbrugh HA, Tacconelli E. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents 2011, 37:195-201. 10.1016/j.ijantimicag.2010.10.023, 21163631.
29. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008, 29:966-968. 10.1086/590661, 18754738.